Meng Yang1, Azalea Ayuningtyas2, Stacey A Kenfield2,3, Howard D Sesso2,4, Hannia Campos1, Jing Ma5, Meir J Stampfer2,5, Jorge E Chavarro6,7,8. 1. Department of Nutrition, Harvard T.H. Chan School of Public Health, 665 Huntington Ave, Boston, MA, 02115, USA. 2. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. 3. Department of Urology, University of California San Francisco School of Medicine, San Francisco, CA, USA. 4. Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. 5. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. 6. Department of Nutrition, Harvard T.H. Chan School of Public Health, 665 Huntington Ave, Boston, MA, 02115, USA. jchavarr@hsph.harvard.edu. 7. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. jchavarr@hsph.harvard.edu. 8. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. jchavarr@hsph.harvard.edu.
Abstract
BACKGROUND: Circulating fatty acids are highly correlated with each other, and analyzing fatty acid patterns could better capture their interactions and their relation to prostate cancer. We aimed to assess the associations between data-derived blood fatty acid patterns and prostate cancer risk. METHODS: We conducted a nested case-control study in the Physicians' Health Study. Fatty acids levels were measured in whole blood samples of 476 cases and their matched controls by age and smoking status. Fatty acid patterns were identified using principal component analysis. Conditional logistic regression was used to estimate odds ratio (OR) and 95 % confidence interval (CI). RESULTS: Two patterns explaining 40.9 % of total variation in blood fatty acid levels were identified. Pattern 1, which mainly reflects polyunsaturated fatty acid metabolism, was suggestively positively related to prostate cancer risk (ORquintile 5 vs. quintile 1 = 1.37, 95 % CI = 0.91-2.05, P trend = 0.07). Pattern 2, which largely reflects de novo lipogenesis, was significantly associated with higher prostate cancer risk (ORquintile5 vs. quintile1 = 1.63, 95 % CI = 1.04-2.55, P trend = 0.02). This association was similar across tumor stage, grade, clinical aggressiveness categories and follow-up time. CONCLUSION: The two patterns of fatty acids we identified were consistent with known interactions between fatty acid intake and metabolism. A pattern suggestive of higher activity in the de novo lipogenesis pathway was related to higher risk of prostate cancer.
BACKGROUND:Circulating fatty acids are highly correlated with each other, and analyzing fatty acid patterns could better capture their interactions and their relation to prostate cancer. We aimed to assess the associations between data-derived blood fatty acid patterns and prostate cancer risk. METHODS: We conducted a nested case-control study in the Physicians' Health Study. Fatty acids levels were measured in whole blood samples of 476 cases and their matched controls by age and smoking status. Fatty acid patterns were identified using principal component analysis. Conditional logistic regression was used to estimate odds ratio (OR) and 95 % confidence interval (CI). RESULTS: Two patterns explaining 40.9 % of total variation in blood fatty acid levels were identified. Pattern 1, which mainly reflects polyunsaturated fatty acid metabolism, was suggestively positively related to prostate cancer risk (ORquintile 5 vs. quintile 1 = 1.37, 95 % CI = 0.91-2.05, P trend = 0.07). Pattern 2, which largely reflects de novo lipogenesis, was significantly associated with higher prostate cancer risk (ORquintile5 vs. quintile1 = 1.63, 95 % CI = 1.04-2.55, P trend = 0.02). This association was similar across tumor stage, grade, clinical aggressiveness categories and follow-up time. CONCLUSION: The two patterns of fatty acids we identified were consistent with known interactions between fatty acid intake and metabolism. A pattern suggestive of higher activity in the de novo lipogenesis pathway was related to higher risk of prostate cancer.
Entities:
Keywords:
Blood fatty acids; Case–control study; Principal component analysis; Prostate cancer
Authors: Paul L Nguyen; Jing Ma; Jorge E Chavarro; Matthew L Freedman; Rosina Lis; Giuseppe Fedele; Christopher Fiore; Weiliang Qiu; Michelangelo Fiorentino; Stephen Finn; Kathryn L Penney; Anna Eisenstein; Fredrick R Schumacher; Lorelei A Mucci; Meir J Stampfer; Edward Giovannucci; Massimo Loda Journal: J Clin Oncol Date: 2010-08-02 Impact factor: 44.544
Authors: P M L Skidmore; J V Woodside; C Mc Master; A Bingham; C Mercer; A Evans; I S Young; J W G Yarnell Journal: Eur J Clin Nutr Date: 2010-01-20 Impact factor: 4.016
Authors: P H Gann; C H Hennekens; F M Sacks; F Grodstein; E L Giovannucci; M J Stampfer Journal: J Natl Cancer Inst Date: 1994-02-16 Impact factor: 13.506
Authors: Jorge E Chavarro; Meir J Stampfer; Hannia Campos; Tobias Kurth; Walter C Willett; Jing Ma Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-01 Impact factor: 4.254
Authors: Francesca L Crowe; Paul N Appleby; Ruth C Travis; Matt Barnett; Theodore M Brasky; H Bas Bueno-de-Mesquita; Veronique Chajes; Jorge E Chavarro; Maria-Dolores Chirlaque; Dallas R English; Robert A Gibson; Graham G Giles; Gary E Goodman; Susanne M Henning; Rudolf Kaaks; Irena B King; Lawrence N Kolonel; Alan R Kristal; Marian L Neuhouser; Song-Yi Park; Gianluca Severi; Afshan Siddiq; Meir J Stampfer; Pär Stattin; Catherine M Tangen; Anne Tjønneland; Dimitrios Trichopoulos; Rosario Tumino; Lynne R Wilkens; Timothy J Key; Naomi E Allen Journal: J Natl Cancer Inst Date: 2014-09-10 Impact factor: 13.506
Authors: Francesca L Crowe; Naomi E Allen; Paul N Appleby; Kim Overvad; Inge V Aardestrup; Nina F Johnsen; Anne Tjønneland; Jakob Linseisen; Rudolf Kaaks; Heiner Boeing; Janine Kröger; Antonia Trichopoulou; Assimina Zavitsanou; Dimitrios Trichopoulos; Carlotta Sacerdote; Domenico Palli; Rosario Tumino; Claudia Agnoli; Lambertus A Kiemeney; H Bas Bueno-de-Mesquita; María-Dolores Chirlaque; Eva Ardanaz; Nerea Larrañaga; José R Quirós; Maria-José Sánchez; Carlos A González; Pär Stattin; Göran Hallmans; Sheila Bingham; Kay-Tee Khaw; Sabina Rinaldi; Nadia Slimani; Mazda Jenab; Elio Riboli; Timothy J Key Journal: Am J Clin Nutr Date: 2008-11 Impact factor: 7.045